K-numberK252209
Device nameIPL Home Use Hair Removal Device (JD-TM016, JD-TM023, JD-TM027, JD-TM028, JD-TM032)
ApplicantFoshan Jindi Electric Appliance Co., Ltd.
Product codeOHT
Device classClass II
Decision dateOct 10, 2025
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The IPL Home Use Hair Removal Device is an over-the-counter, home-use device that removes unwanted hair using Intense Pulsed Light (IPL) technology. It is indicated for hair removal and permanent reduction in hair regrowth, defined as long-term stable reduction measured at 6, 9, and 12 months after treatment completion. The device works below the skin's surface without cutting or pulling, and includes five models (JD-TM016, JD-TM023, JD-TM027, JD-TM028, JD-TM032) with identical intended use but differences in appearance, dimensions, and light output parameters.

Technological characteristics

The subject device uses Intense Pulsed Light from a xenon arc flashlamp with wavelength range 550–1200 nm, energy density 2–7 J/cm², spot size 3.0–3.3 cm², and pulse duration 10 ms ± 2 ms. It has 5–9 output intensity levels, manual finger-switch activation, a skin-contact sensor, integrated cooling function, and is powered by external adapter (100–240V, 50/60 Hz). Minor differences from predicate include dimension variations and higher intensity level options (5–9 levels versus 5 levels).

Test standards cited

Biocompatibility: ISO 10993-5, ISO 10993-10, ISO 10993-23. Electrical safety and EMC: IEC 60601-1, IEC 60601-1-2, IEC 60601-1-11, IEC 60601-2-57. Eye safety: IEC 62471. Software: basic documentation level with system validation testing. Usability: FDA guidance on human factors and usability engineering to medical devices (February 2016).

Substantial equivalence argument

The subject device has the same intended use, mode of action, and similar operational characteristics as the predicate device (Shenzhen Ulike IPL Home Use Hair Removal, K230122). Non-clinical testing demonstrates that the device is safe and effective as the predicate, and minor differences in dimensions and intensity levels do not raise safety or efficacy concerns. Performance data supports substantial equivalence to both the predicate and reference devices.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →